In addition, the findings showed that the incidence rate of CRS in GM-CSF-knockout CAR-T cells is significantly lower compared with the rate of CRS in GM-CSF-intact CAR-T cells. This evidence concerns the gene CSF2 and congenital rubella syndrome.